More about

Ovarian Cancer

News
July 11, 2023
3 min read
Save

Accounting, hairdressing among professions linked to increased ovarian cancer risk

Accounting, hairdressing among professions linked to increased ovarian cancer risk

Certain occupations — including accountancy, hairdressing, sales and sewing — may be associated with increased risk for ovarian cancer, according to study results published in Occupational and Environmental Medicine.

CME
Video

Disparities in Ovarian Cancer: Increasing Awareness to Improve Risk Assessment and Outcomes

Disparities in Ovarian Cancer: Increasing Awareness to Improve Risk Assessment and Outcomes
1.50 CME
1.50 CNE
90 MINS
$0 FEE
News
June 12, 2023
2 min read
Save

Mirvetuximab soravtansine data ‘practice changing’ for subset of women with ovarian cancer

Mirvetuximab soravtansine data ‘practice changing’ for subset of women with ovarian cancer

CHICAGO — Mirvetuximab soravtansine-gynx extended survival of women with platinum-resistant ovarian cancer and high folate receptor-alpha expression, according to a study that compared the agent with investigator’s choice of chemotherapy.

News
June 03, 2023
2 min read
Save

Olaparib-durvalumab regimen prolongs PFS for certain women with advanced ovarian cancer

Olaparib-durvalumab regimen prolongs PFS for certain women with advanced ovarian cancer

CHICAGO — First-line chemotherapy plus bevacizumab and durvalumab — followed by maintenance durvalumab, bevacizumab and olaparib — extended PFS compared with standard of care for women with non-BRCA-mutated advanced ovarian cancer.

News
May 18, 2023
3 min read
Save

Close relatives of patients with pancreatic cancer at higher risk for several malignancies

Close relatives of patients with pancreatic cancer at higher risk for several malignancies

First-degree relatives of individuals with pancreatic ductal adenocarcinoma who harbored certain cancer-associated pathogenic germline variants had significantly higher risk for developing several cancer types, study results showed.

News
May 03, 2023
2 min read
Save

Mirvetuximab soravtansine-gynx extends survival for certain women with ovarian cancer

Mirvetuximab soravtansine-gynx extends survival for certain women with ovarian cancer

Mirvetuximab soravtansine-gynx conferred a 33% reduction in risk for death compared with chemotherapy for women with folate receptor alpha-positive platinum-resistant ovarian cancer, according to topline data from the agent’s manufacturer.

News
April 19, 2023
3 min read
Save

Exome sequencing identifies cancer predisposition-gene carriers screening guidelines miss

Exome sequencing identifies cancer predisposition-gene carriers screening guidelines miss

Whole-exome sequencing identified carriers of predisposition genes for hereditary breast and ovarian cancer or Lynch syndrome who, under current guidelines, would not have qualified for genetic testing, according to study results.

News
March 27, 2023
2 min read
Save

Niraparib maintenance therapy fails to significantly extend OS in recurrent ovarian cancer

Niraparib maintenance therapy fails to significantly extend OS in recurrent ovarian cancer

Niraparib did not significantly extend OS among women with recurrent ovarian cancer, according to long-term follow-up results of the ENGOT-OV16/NOVA trial presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

News
March 27, 2023
2 min read
Save

Neoadjuvant olaparib feasible for women with germline-mutant ovarian cancer

Neoadjuvant olaparib feasible for women with germline-mutant ovarian cancer

Neoadjuvant therapy with olaparib showed feasibility for women with germline-mutant ovarian cancer, according to results of the NOW trial presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

News
March 22, 2023
2 min read
Save

Mailing HPV kits effective for increasing cervical cancer screening uptake

Mailing HPV kits effective for increasing cervical cancer screening uptake

Mailing HPV self-sampling kits to women who are overdue for cervical cancer screening was cost-effective in increasing screening uptake compared with usual care, according to an economic evaluation published in JAMA Network Open.

View more